Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primaquine Regimens for P. Vivax Malaria in Brazil
NCT03610399Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Apr 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of primaquine in malaria, sponsored by Centers for Disease Control and Prevention. Primary endpoint: Adequate Clinical and Parasitologic Response at Day 28. Started Apr 2018; status: completed.
02
Drugs
primaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03610399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03610399.